Physician profile
Aamer Abbass
NPI 1689081119
$13,394.68
in general payments reported to CMS, 2019-2025
18 companies · $390 in 2025
The $390 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,113 · 2020: $725 · 2021: $833 · 2022: $2,228 · 2023: $5,687 · 2024: $2,418 · 2025: $390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,531 · Food and Beverage: $2,964.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,531.03 |
| Food and Beverage | $2,963.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $4,998.77 | 2019-2024 | Single Use Electrosurgical Knife Kd-655, Disposable Distal Attachment, Single Use Electrosurgical Hemostatic Forceps |
| Boston Scientific Corporation | $3,396.80 | 2021-2025 | Wallflex Duodenal, Axios, Exalt Model D |
| Abbvie INC. | $1,228.80 | 2019-2025 | Creon, Linzess |
| Ovesco Endoscopy USA, INC. | $967.52 | 2023 | |
| Medtronic, INC. | $520.90 | 2021-2024 | Endoflip, Nexpowder |
| Takeda Pharmaceuticals U.S.A., INC. | $506.75 | 2019-2023 | Entyvio |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $290.77 | 2020-2022 | |
| Olympus America INC. | $218.66 | 2023-2025 | Endoclot Phs, Evis Exera III Video System Center |
| Gilead Sciences, INC. | $212.90 | 2019 | |
| Steris Corporation | $206.51 | 2019-2024 | |
| Amgen INC. | $149.79 | 2025 | Uplizna |
| Endogastric Solutions, INC | $133.82 | 2023 | Esophyx |
| Erbe USA INC | $133.22 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $128.35 | 2024 | Iqirvo |
| Janssen Scientific Affairs, LLC | $105.33 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $95.81 | 2023 | Zeposia |
| Fujifilm Healthcare Americas Corporation | $85.00 | 2024 | |
| Conmed Corporation | $14.98 | 2025 | Conmed Biliary |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aamer Abbass listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.